Clinical Trial Update: Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating early effects of intensive lipid lowering with ezetimibe/simvastatin (Vytorin) on plaque characteristics in acute coronary syndrome, as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Yonsei University | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED